Canada's MDEL Rules Are Changing December 14, 2026 — Here's What Foreign Distributors Need to Know
An overview of Health Canada's Phase 2 MDEL modernization, covering distributor exemptions, mandatory supplier list disclosures, and what changes ahead of the December deadline.
Read More
Your Medical Device Is Approved in Canada. So Why Can't You Sell It Yet?
Discover why getting your medical device licensed is only half the battle, and how partnering with an established MDEL holder enables a faster, compliant market entry.
Read More
Do You Need a Drug Establishment Licence (DEL) to Sell Pharmaceuticals in Canada?
Explore whether your pharmaceutical or biotech company needs a Drug Establishment Licence (DEL) to operate in Canada, and discover how partnering with an established commercialization provider can streamline your market entry.
Read More
Addressing the Challenges of Comparator Drug Sourcing for Clinical Trials
Establishing a comparator sourcing strategy early in protocol development is essential to minimize time, cost and hurdles in procuring drugs for clinical trials.
📄 View Blog
Listening to Clients and Expanding Across the Clinical Supply Chain
How Globyz Biopharma Services evolved into a full-service clinical trials partner — offering end-to-end solutions from comparator sourcing to trial operations.
📄 View Blog